KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in id-KLH (26)

Tuesday
Aug302011

NCT01426828

Id-KLH Vaccine + T Cells

Conditions: Multiple Myeloma
Sponsors: Abramson Cancer Center of the University of Pennsylvania
Phase 2

Friday
Jul302010

NCT01174082

Donor Lymphocyte Infusion for Myeloma

Conditions: Myeloma
Sponsors: M.D. Anderson Cancer Center
Phase 2

Thursday
Oct012009

NCT00988312

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

Conditions: Multiple Myeloma, Plasmocytoma
Sponsors: University Hospital Carl Gustav Carus
Phase I

Wednesday
Apr082009

NCT00878410

Immunoglobulin and QS-21 in Patients With Follicular Lymphomas 

Conditions: Lymphoma
Sponsors: National Cancer Institute (NCI)
Phase I

Thursday
Feb212008

NCT00621036

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Conditions: Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer
Sponsors: Simmons Cancer Center
Phase II

Wednesday
Dec122007

NCT00574886

Tuesday
Jul312007

NCT00510471

Wednesday
Jun202007

NCT00490529

Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Conditions: Lymphoma, Mantle-Cell
Sponsors: Stanford University
Phase II

Thursday
Mar012007

NCT00019097

Vaccine Therapy in Treating Patients With Multiple Myeloma

Conditions: Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Neoplasm
Sponsors: National Cancer Institute (NCI)
Phase II

Wednesday
May102006

NCT00324831